Physician profile
Vikas Sayal
NPI 1811109226
$84,942.32
in general payments reported to CMS, 2019-2025
53 companies · $3,006 in 2025
The $3,006 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,911 · 2020: $3,603 · 2021: $21K · 2022: $18K · 2023: $27K · 2024: $2,844 · 2025: $3,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $9,852 · Travel and Lodging: $967 · Education: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,550.00 |
| Food and Beverage | $9,851.58 |
| Travel and Lodging | $967.05 |
| Education | $386.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $35,413.63 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $33,805.76 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Sunovion Pharmaceuticals INC. | $2,226.55 | 2019 | |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $1,595.30 | 2021-2025 | Dupixent |
| Electromed, INC. | $1,203.85 | 2019-2025 | Smartvest |
| Intuitive Surgical, INC. | $1,128.43 | 2022-2024 | Da Vinci Surgical System |
| Mylan Specialty L.P. | $1,024.27 | 2019-2024 | Yupelri, Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $895.28 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $745.73 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $568.13 | 2019-2025 | Opsynvi, Uptravi |
| Merck Sharp & Dohme LLC | $544.41 | 2022-2025 | Winrevair |
| Grifols USA, LLC | $373.33 | 2020-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $309.38 | 2020-2025 | Glassia |
| Genentech USA, INC. | $265.74 | 2019-2023 | Xolair |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $257.09 | 2019-2024 | (8874) Incourage |
| Boston Scientific Corporation | $250.19 | 2019-2023 | Icefx Cryoablation System |
| Amgen INC. | $248.91 | 2021-2025 | Tezspire |
| Abbvie INC. | $235.23 | 2021-2024 | Avycaz, Dalvance |
| Verona Pharma, INC. | $235.16 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $205.31 | 2024-2025 | Inspire |
| Insmed, INC. | $176.56 | 2024-2025 | Arikayce |
| Daiichi Sankyo INC. | $155.90 | 2022 | |
| Foundation Medicine, INC. | $148.30 | 2021 | |
| Allergan, INC. | $147.56 | 2019 | |
| Baxter Healthcare | $146.81 | 2023-2025 | Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Sanofi-Aventis U.S. LLC | $136.47 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $114.32 | 2020-2024 | |
| Cumberland Pharmaceuticals, INC. | $113.46 | 2019 | |
| Covis Pharma Gmbh | $112.06 | 2021-2022 | |
| Inogen, INC. | $107.04 | 2021-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Jazz Pharmaceuticals INC. | $91.30 | 2025 | |
| Vifor Pharma, INC. | $78.41 | 2025 | Veltassa, Zemaira |
| Viatris Specialty LLC | $66.14 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $33.19 | 2020 | |
| United Therapeutics Corporation | $33.03 | 2021 | |
| Johnson & Johnson Health Care Systems INC. | $32.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.08 | 2023 | |
| Harmony Biosciences LLC | $20.32 | 2023 | Wakix |
| Csl Behring | $16.82 | 2019 | |
| La Jolla Pharmaceutical Company | $16.78 | 2025 | Zevtera |
| Fisher & Paykel Healthcare INC | $15.29 | 2023 | Fisher & Paykel Healthcare |
| Breas Medical, INC. | $13.83 | 2023 | Vivo 45 Ls |
| Pfizer INC. | $11.48 | 2023 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$187.21 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Sayal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.